Tregs are known to be major inhibitors of effective immune responses in ccRCC, suppressing CD8+ T cell activation via cytokines such as transforming growth factor-β and interleukin 10, and depleting Interleukin 2 to block clonal expansion (69, 70). The gene discussed is IL10; the disease is nonpapillary renal cell carcinoma.